Chargement en cours...
NEXT GENERATION ORAL PrEP: BEYOND TENOFOVIR
PURPOSE: Clinical trials of oral pre-exposure prophylaxis (PrEP) have focused testing on regimens of tenofovir (TDF) with or without emtricitabine (FTC). However, TDF may be associated with toxicities (renal, bone) and FTC may select for drug resistance. In this review, we discuss agents that might...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3732461/ https://ncbi.nlm.nih.gov/pubmed/23032733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COH.0b013e328358b9ce |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|